A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant

Nucleic Acids Res. 2015 Feb 18;43(3):1317-31. doi: 10.1093/nar/gkv008. Epub 2015 Jan 20.

Abstract

Technologies that delivery antigen-encoded plasmid DNA (pDNA) to antigen presenting cell and their immune-activation are required for the success of DNA vaccines. Here we report on an artificial nanoparticle that can achieve these; a multifunctional envelope-type nanodevice modified with KALA, a peptide that forms α-helical structure at physiological pH (KALA-MEND). KALA modification and the removal of the CpG-motifs from the pDNA synergistically boosted transfection efficacy. In parallel, transfection with the KALA-MEND enhances the production of multiple cytokines and chemokines and co-stimulatory molecules via the Toll-like receptor 9-independent manner. Endosome-fusogenic lipid envelops and a long length of pDNA are essential for this immune stimulation. Furthermore, cytoplasmic dsDNA sensors that are related to the STING/TBK1 pathway and inflammasome are involved in IFN-β and IL-1β production, respectively. Consequently, the robust induction of antigen-specific cytotoxic T-lymphoma activity and the resulting prophylactic and therapeutic anti-tumor effect was observed in mice that had been immunized with bone marrow-derived dendritic cells ex vivo transfected with antigen-encoding pDNA. Collectively, the KALA-MEND possesses dual functions; gene transfection system and immune-stimulative adjuvant, those are both necessary for the successful DNA vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Animals
  • Antigen-Presenting Cells / immunology*
  • CpG Islands*
  • DNA-Binding Proteins / chemistry*
  • Female
  • Histocompatibility Antigens Class I / biosynthesis
  • Lipids / chemistry*
  • Mice
  • Mice, Inbred C57BL
  • Nanoparticles*
  • Neoplasms / therapy
  • Peptides / chemistry*
  • Plasmids*
  • T-Lymphocytes, Cytotoxic / immunology
  • Vaccines, DNA / administration & dosage*

Substances

  • Adjuvants, Immunologic
  • DNA-Binding Proteins
  • Histocompatibility Antigens Class I
  • KALA amphipathic peptide
  • Lipids
  • Peptides
  • Vaccines, DNA